DOI: 10.1038/385165a0 Melanocortin Receptor Selectivity Profiling Comparative receptor binding studies have systematically characterised MT-2s binding affinities across MC1RMC5R relative to native -MSH, NDP--MSH, MT-1, and Bremelanotide establishing it as the reference broad-spectrum melanocortin agonist for multi-receptor pathway studies and the benchmark compound in melanocortin analogue SAR research
Both compounds bind to the same GHRH receptors on pituitary somatotrophs, creating competitive inhibition rather than synergy
Symptoms include feeling shaky and dizzy, rapid heart rate, chest trouble, headache, sweating, blurred vision, or hunger indigestion
Boosts Antioxidant Defenses: Delivers key antioxidants, including Glutathione and Vitamin C, that help neutralize free radicals and protect skin from early environmental aging stressors
Disclaimer: This article is provided for research and informational purposes only